Brainstorm Cell Therapeutics, Inc. (BCLI): Sotuvga nisbatan narx
NurOwn platformasining istiqbollari FDA ning qat'iy nazorati bilan cheklangan bo'lib, bu Brainstorm Cell (BCLI) uchun barqaror raqobatbardosh ustunlik yaratilishiga to'sqinlik qiladi. Reagentlar yetkazib berishining beqarorligi va xorijiy patentlarni himoya qilishdagi murakkabliklar xavflarni yanada kuchaytiradi. Kelajakdagi o'sish yuqori marjali hujayra terapiyasi usulini kengaytirishga asoslangan. Savdo daromadlariga nisbatan narx koeffitsiyenti beqaror baholashlarni aks ettiradi, esa ko'rsatkichning joriy qiymatini ifodalaydi.
Brainstorm Cell Therapeutics, Inc. (BCLI) kompaniyasining tahliliy kesimlari
- kotirovkalar va tahlilchilar prognozi:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Brainstorm Cell|BCLI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati BrainStorm Cell Therapeutics Inc.|BCLI - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Brainstorm Cell|BCLI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi BrainStorm Cell Therapeutics|Tezkor likvidlik brainstorm-cell.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
BCLI - Sof foyda|Kutilayotgan foyda Brainstorm Cell|BCLI - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Brainstorm Cell Therapeutics Inc.|BCLI - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Brainstorm Cell|BCLI - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda BrainStorm Cell Therapeutics|BCLI - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi brainstorm-cell.com|BCLI - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Brainstorm Cell
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:BCLI - brainstorm-cell.com
Brainstorm Cell (BCLI) kompaniyasining neyrodegeneratsiya terapiyasi bo'yicha patent ustunligiga erishishdagi kurashi uning bozor kapitalizatsiyasiga generatsiya qilingan daromadlar nisbatida bevosita ta'sir ko'rsatadi. Sotuvlar nisbatidagi narx (P/S) ko'rsatkichi investorlarning sotuvlarning har bir dollari uchun to'lashga tayyor bo'lgan premiumini o'lchaydi va kelgusidagi kengayishga bo'lgan kutishlarni aks ettiradi. Kompaniyaning P/S monitoringini tahlil qilish orqali strategiyani qayta baholash uchun muhim nuqtalarni yoki aktivlarning keskin kamayishi xatarlarini aniqlash mumkin.
Brainstorm Cell raqobatchilari
Kapitalizatsiyaning sotish hajmiga nisbati BIIB|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|Regencell Bioscience Ltd (RGC) - Sotuvga nisbatan narx|AXSM - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|Xenon Pharmaceuticals (XENE) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati vikingtherapeutics.com|Kapitalizatsiyaning daromadga nisbati SUPN|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Kapitalizatsiyaning daromadga nisbati Harmony Corp HRMY|P/S multiplikatori BHVN (Biohaven Ltd.)|amylyx.com (AMLX) - Sotuvga nisbatan narx|TRVI - Narxning daromadga nisbati|PRAX: Narxning daromadga nisbati|Anavex Corp (AVXL) - Narxning daromadga nisbati|CBLL (CeriBell EEG) - Narxning daromadga nisbati|PRTA (Prothena Biosciences) - P/S multiplikatori|Narxning daromadga nisbati ALEC|P/S multiplikatori ANNX|Kapitalizatsiyaning daromadga nisbati omeros.com OMER|Narxning daromadga nisbati Neurogene Corp NGNE|AC Immune Inc - Narxning daromadga nisbati|Voyager Therapeutics - P/S multiplikatori|Narx/daromad koeffitsiyenti neumoratx.com NMRA|Scilex (SCLX) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati TVGN|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Sotuvga nisbatan narx Cognition Therapeutics Inc. CGTX|Kapitalizatsiyaning daromadga nisbati IKT (Inhibikase Therapeutics)|P/S multiplikatori cassavasciences.com (SAVA)|Narxning daromadga nisbati Assertio ASRT|Bozor kapitallashuvining daromadga nisbati COYA|VTGN - Narxning daromadga nisbati|Sotuvga nisbatan narx Ovid Therapeutics Inc.|ABOS: P/S multiplikatori|CRVO (cervomed.com) - Narxning daromadga nisbati|Narxning daromadga nisbati Alterity Therapeutics Ltd.|CLNN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori PEPG|P/S multiplikatori Jupiter Neurosciences, Inc. (JUNS)|P/S multiplikatori RLMD (Relmada Therapeutics)|Narx/daromad koeffitsiyenti annovisbio.com (ANVS)|GRCE - Narxning daromadga nisbati|AIFF (Firefly Neuroscience, Inc.) - Kapitalizatsiya va daromad nisbati|anewmeds.com (KLTO) - Narxning daromadga nisbati|NRSN - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati RVPH|MTVA (MetaVia, Inc.) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati NeurAxis (NRXS)|HSDT - Sotuvga nisbatan narx|Narxning daromadga nisbati Passage Bio PASG|Bozor kapitallashuvining daromadga nisbati NEUP|NERV - Narxning daromadga nisbati|athira.com (ATHA) - Kapitalizatsiyaning daromadga nisbati|ADXN (Addex Therapeutics Ltd) - Kapitalizatsiyaning daromadga nisbati|Alzamend Neuro - Bozor kapitallashuvining daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Protagenic (PTIX)|P/S multiplikatori KTTA|CRGT - Sotuvga nisbatan narx|Narxning daromadga nisbati Avenue Therapeutics, Inc. ATXI|Cara Therapeutics Inc. - Narxning daromadga nisbati|CHRO - Narxning daromadga nisbati|ELYM: Narxning daromadga nisbati|ITCI: P/S multiplikatori|LBPH (longboardpharma.com) - Narxning daromadga nisbati|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati NKGen Biotech Inc (NKGN)|Narxning daromadga nisbati NeuroBo (NRBO)|Narxning daromadga nisbati SAGE (Sage Therapeutics Inc)|P/S multiplikatori SNPX (Synaptogenix, Inc.)|Narx/daromad koeffitsiyenti trevena.com (TRVN)|VIGL - Narxning daromadga nisbati|WENA (anewmeds.com) - Kapitalizatsiya va daromad nisbati|CERE: P/S multiplikatori
